Conference
Activating mutations in AKT1/PIK3CA are associated with poor clinical outcomes in metastatic prostate cancer (mPC)
Authors
Fu SYF; Murtha A; Herberts C; Yip S; Angeles A; Hotte SJ; Alshangiti A; Tran B; Taavitsainen S; Annala M
Volume
30
Pagination
pp. 347-347
Publisher
OXFORD UNIV PRESS
Publication Date
October 1, 2019
Name of conference
44th Congress of the European-Society-for-Medical-Oncology (ESMO)
Conference place
SPAIN, Barcelona
Conference start date
September 27, 2019
Conference end date
October 1, 2019
Conference proceedings
ANNALS OF ONCOLOGY
ISSN
0923-7534